Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Int Wound J ; 21(6): e14911, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38831721

RESUMEN

Full-thickness skin graft (FTSG) reconstructions of lower limbs are especially prone to wound complications. Negative pressure wound therapy (NPWT) enhances wound healing, but no broad evidence exists if it promotes graft take of lower leg FTSGs. In this investigator-initiated, prospective, randomised and controlled trial, 20 patients with ambulatory FTSG reconstruction for lower limb skin cancers were randomised for postoperative treatment with either NPWT, or conventional dressings. As outcomes, adherence of the skin graft 1 week postoperatively, any wound complications within 3 months, including ≥3 weeks delayed wound healing, and the number of additional postoperative visits were compared. In both groups, grafts adhered equally well (p = 0.47); 80% of NPWT-treated and 100% of control group grafts adhered >90%. There was no significant difference in the number of postoperative complications/delayed wound healing (p = 0.65); 70% of patients in the NPWT and 50% in the control group developed a wound complication. Both groups had an equal number of patients with at least three additional control visits (p = 1.0). The study was discontinued after 20 patients were recruited, as no benefit from NPWT was seen. To conclude, the study showed no benefit from NPWT for lower limb FTSGs.


Asunto(s)
Terapia de Presión Negativa para Heridas , Neoplasias Cutáneas , Trasplante de Piel , Cicatrización de Heridas , Humanos , Terapia de Presión Negativa para Heridas/métodos , Masculino , Femenino , Trasplante de Piel/métodos , Persona de Mediana Edad , Anciano , Neoplasias Cutáneas/cirugía , Estudios Prospectivos , Extremidad Inferior/cirugía , Anciano de 80 o más Años , Resultado del Tratamiento , Adulto
3.
Acta Derm Venereol ; 103: adv6579, 2023 Aug 16.
Artículo en Inglés | MEDLINE | ID: mdl-37584092

RESUMEN

Artificial daylight photodynamic therapy is a near-painless treatment for actinic keratoses, which can be performed indoors using a controlled light dose. Daylight photodynamic therapy is approved only for treatment of grade I-II actinic keratoses. The aim of this study was to evaluate whether fractional laser pre-treatment improves the outcomes of daylight photodynamic therapy for actinic keratoses of all grades. In addition, the study compared the outcomes of artificial and natural daylight photodynamic therapy. This randomized single-blinded split-side comparative study included 60 patients with ≥ 2 actinic keratoses of the head. Fractional laser pre-treatment was assigned randomly for actinic keratoses on 1 side of the head and, subsequently, the entire treatment area was treated with artificial or natural daylight photodynamic therapy. Fractional laser-mediated daylight photodynamic therapy achieved significantly higher complete clearance (50.0% vs 30.3%, p = 0.04), partial clearance (78.6% vs 50.0%, p < 0.01) and lesion-specific clearance (86.2% vs 70.2%, p < 0.01) than daylight photodynamic therapy alone at the 6-month follow-up. No significant differences were found in the outcomes of artificial vs natural daylight photodynamic therapy or grade I lesions vs grade II-III lesions. Thus, fractional laser pre-treatment appears to significantly increase the efficacy of artificial and natural daylight photodynamic therapy, and to be suitable for treatment of actinic keratoses of all grades.


Asunto(s)
Queratosis Actínica , Terapia por Láser , Fotoquimioterapia , Terapia por Láser/métodos , Fármacos Fotosensibilizantes , Queratosis Actínica/diagnóstico , Queratosis Actínica/terapia , Finlandia , Resultado del Tratamiento , Humanos , Masculino , Femenino , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años
4.
BMJ Open ; 12(11): e062673, 2022 11 21.
Artículo en Inglés | MEDLINE | ID: mdl-36410819

RESUMEN

OBJECTIVES: Exact wound diagnosis is essential for successful wound management and a holistic care of the patient suffering from a wound. Wound management has been traditionally seen as a nursing area, but this can lead to considerable delays in wound diagnostics. A diagnostic delay has been recognised as an element of diagnostic error, which, in turn, affects patient safety. The aim of this cohort study was to examine diagnostic delays of chronic wound within primary care. SETTING: A specialised diagnostic unit, a wound care team, was established in the primary healthcare with the objective of reducing diagnostic and treatment delays in primary care. PARTICIPANTS: The data consists of 197 consecutive patients attending their first appointment with the wound care team in 2016. The collected data included basic demographics, information about the clinical pathway, including doctor's appointments in primary and specialised care, as well as the International Classification of Diseases 10th Revision (ICD-10) diagnostic codes. PRIMARY AND SECONDARY OUTCOME MEASURES: The diagnostic delays were calculated in days and divided into three groups: (1) patient-related delay, (2) diagnostic delay and (3) organisational delay. RESULTS: The median duration of a patient-related delay was 2 days (IQR 0-14), whereas a physician's first evaluation was performed at a median of 8 (1-32) days from wound appearance and the correct diagnosis by the wound care team was established in a median of 57 (33-100) days. The organisational delay from first contact to diagnosis was a median of 41 (22-80) days. Only one in three patients had a diagnostic delay of less than 4 weeks. CONCLUSIONS: According to this study, the diagnostic delay occurs within primary care, as an organisational delay from first contact to correct diagnosis. It is possible to arrange an optimal pathway of care in which a holistic wound care process starts within primary care.


Asunto(s)
Vías Clínicas , Diagnóstico Tardío , Humanos , Estudios de Cohortes , Registros , Atención Primaria de Salud
5.
Acta Derm Venereol ; 102: adv00815, 2022 Nov 14.
Artículo en Inglés | MEDLINE | ID: mdl-36281811

RESUMEN

Malignant melanoma poses a clinical diagnostic problem, since a large number of benign lesions are excised to find a single melanoma. This study assessed the accuracy of a novel non-invasive diagnostic technology, hyperspectral imaging, for melanoma detection. Lesions were imaged prior to excision and histopathological analysis. A deep neural network algorithm was trained twice to distinguish between histopathologically verified malignant and benign melanocytic lesions and to classify the separate subgroups. Furthermore, 2 different approaches were used: a majority vote classification and a pixel-wise classification. The study included 325 lesions from 285 patients. Of these, 74 were invasive melanoma, 88 melanoma in situ, 115 dysplastic naevi, and 48 non-dysplastic naevi. The study included a training set of 358,800 pixels and a validation set of 7,313 pixels, which was then tested with a training set of 24,375 pixels. The majority vote classification achieved high overall sensitivity of 95% and a specificity of 92% (95% confidence interval (95% CI) 0.024-0.029) in differentiating malignant from benign lesions. In the pixel-wise classification, the overall sensitivity and specificity were both 82% (95% CI 0.005-0.005). When divided into 4 subgroups, the diagnostic accuracy was lower. Hyperspectral imaging provides high sensitivity and specificity in distinguishing between naevi and melanoma. This novel method still needs further validation.


Asunto(s)
Melanoma , Nevo Pigmentado , Neoplasias Cutáneas , Humanos , Imágenes Hiperespectrales , Melanoma/patología , Neoplasias Cutáneas/patología , Nevo Pigmentado/patología , Sensibilidad y Especificidad , Melanoma Cutáneo Maligno
6.
J Clin Med ; 11(7)2022 Mar 30.
Artículo en Inglés | MEDLINE | ID: mdl-35407522

RESUMEN

Several optical imaging techniques have been developed to ease the burden of skin cancer disease on our health care system. Hyperspectral images can be used to identify biological tissues by their diffuse reflected spectra. In this second part of a three-phase pilot study, we used a novel hand-held SICSURFIS Spectral Imager with an adaptable field of view and target-wise selectable wavelength channels to provide detailed spectral and spatial data for lesions on complex surfaces. The hyperspectral images (33 wavelengths, 477-891 nm) provided photometric data through individually controlled illumination modules, enabling convolutional networks to utilise spectral, spatial, and skin-surface models for the analyses. In total, 42 lesions were studied: 7 melanomas, 13 pigmented and 7 intradermal nevi, 10 basal cell carcinomas, and 5 squamous cell carcinomas. All lesions were excised for histological analyses. A pixel-wise analysis provided map-like images and classified pigmented lesions with a sensitivity of 87% and a specificity of 93%, and 79% and 91%, respectively, for non-pigmented lesions. A majority voting analysis, which provided the most probable lesion diagnosis, diagnosed 41 of 42 lesions correctly. This pilot study indicates that our non-invasive hyperspectral imaging system, which involves shape and depth data analysed by convolutional neural networks, is feasible for differentiating between malignant and benign pigmented and non-pigmented skin tumours, even on complex skin surfaces.

7.
Acta Derm Venereol ; 101(2): adv00404, 2021 Feb 19.
Artículo en Inglés | MEDLINE | ID: mdl-33491093

RESUMEN

Previous research presents pulsed dye laser-mediated photodynamic therapy as a promising alternative to conventional red-light photodynamic therapy. In this study, 60 patients with 2 or more actinic keratoses randomly received either of these treatments on each side of the head. A physician blinded to the treatment evaluated treatment response at 6 months for each lesion, as completely, partially or not healed. Significantly lower complete clearance rates (10.3% vs 44.9%) and lesion-specific complete clearance rates were found for pulsed dye laser-mediated photodynamic therapy (47.9%) vs conventional red-light photodynamic therapy (73.4%). Significantly lower pain scores were found for pulsed dye laser-mediated photodynamic therapy, with a mean numerical rating of 2.3, compared with 4.1 for conventional red-light photodynamic therapy. The study population had a mean of 7.9 lesions, and 78% of patients had been treat-ed previously for actinic keratoses on the treatment area. To conclude, in a population with severe sun dam-age, pulsed dye laser-mediated photodynamic therapy seems less effective than conventional red-light photo-dynamic therapy. Pulsed dye laser-mediated photodynamic therapy may still be a treatment option for patients who are not compliant with conventional red-light photodynamic therapy.


Asunto(s)
Queratosis Actínica , Láseres de Colorantes , Fotoquimioterapia , Ácido Aminolevulínico/efectos adversos , Humanos , Queratosis Actínica/diagnóstico , Queratosis Actínica/tratamiento farmacológico , Láseres de Colorantes/efectos adversos , Fotoquimioterapia/efectos adversos , Fármacos Fotosensibilizantes/efectos adversos , Resultado del Tratamiento
8.
Skin Appendage Disord ; 6(1): 37-40, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-32021860

RESUMEN

Hidradenitis suppurativa (HS) is a chronic and recurrent inflammatory skin disorder affecting mainly the areas rich in apocrine sweat glands, such as the axillae, groins and buttocks. The role of mechanical pressure and friction due to clothing in the pathogenesis of HS lesions has been previously stressed. Here, we report 2 middle-aged men who presented with HS lesions/HS-like lesions on their amputation stump and review 2 additional cases from the literature. Management was challenging as 2 patients needed tumor necrosis αinhibitor while deroofing/surgery was the option for the 2 others. These cases highlight that mechanical pressure and friction are environmental factors that can play a role in the pathogenesis of HS lesions.

9.
Int Wound J ; 17(2): 363-369, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31837117

RESUMEN

Below-knee dermatological surgery has a high risk of complications such as wound infection, bleeding, and necrosis. In this study, we evaluated the impact of preoperative appointments on complication risks. We searched the medical records of the Helsinki University Central Hospital (HUS) Dermatosurgery unit for all below-knee surgeries during 2016, when no preoperative nurse appointments were carried out, and compared it with 2018, when preoperative appointments for risk patients were introduced. The study included 187 patients in 2016 and 179 patients in 2018, of whom 68 (about one third) attended preoperative appointments. At the appointments, risk factors were evaluated, and compression therapy was introduced when possible. The results show complication rates of 13.4% in 2016 vs 10.1% in 2018 (P = .33), despite significantly higher risks in the 2018 patient group. The odds ratio for complications in appointment attendees vs non-attendees was reduced after adjustments to 0.58; however, this was insignificant (P = .47). The odds of complications for skin grafts were considerably higher: 11.33 vs other surgery techniques (P = .00). In conclusion, the introduction of preoperative appointments appeared to reduce complications in below-knee surgery. For graft reconstructions, complication risk is high, even with carefully planned pre- and postoperative care. Further studies are needed to evaluate preventable risk factors of below-knee graft reconstructions.


Asunto(s)
Citas y Horarios , Procedimientos Quirúrgicos Dermatologicos/efectos adversos , Cuidados Posoperatorios/métodos , Complicaciones Posoperatorias/diagnóstico , Neoplasias Cutáneas/cirugía , Anciano , Femenino , Finlandia/epidemiología , Estudios de Seguimiento , Humanos , Incidencia , Masculino , Complicaciones Posoperatorias/epidemiología , Pronóstico , Estudios Retrospectivos , Factores de Riesgo
10.
J Wound Care ; 28(Sup6): S1-S92, 2019 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-31169055

Asunto(s)
Heridas y Lesiones/terapia , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/complicaciones , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/diagnóstico , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/patología , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/terapia , Trastornos de la Coagulación Sanguínea/complicaciones , Trastornos de la Coagulación Sanguínea/diagnóstico , Trastornos de la Coagulación Sanguínea/patología , Trastornos de la Coagulación Sanguínea/terapia , Calcifilaxia/complicaciones , Calcifilaxia/diagnóstico , Calcifilaxia/patología , Calcifilaxia/terapia , Eritema Indurado/complicaciones , Eritema Indurado/diagnóstico , Eritema Indurado/patología , Eritema Indurado/terapia , Trastornos Fingidos/complicaciones , Trastornos Fingidos/diagnóstico , Trastornos Fingidos/terapia , Hidradenitis Supurativa/complicaciones , Hidradenitis Supurativa/diagnóstico , Hidradenitis Supurativa/patología , Hidradenitis Supurativa/terapia , Humanos , Vasculitis por IgA/complicaciones , Vasculitis por IgA/diagnóstico , Vasculitis por IgA/patología , Vasculitis por IgA/terapia , Livedo Reticularis/complicaciones , Livedo Reticularis/diagnóstico , Livedo Reticularis/patología , Livedo Reticularis/terapia , Grupo de Atención al Paciente , Poliarteritis Nudosa/complicaciones , Poliarteritis Nudosa/diagnóstico , Poliarteritis Nudosa/patología , Poliarteritis Nudosa/terapia , Piodermia Gangrenosa/complicaciones , Piodermia Gangrenosa/diagnóstico , Piodermia Gangrenosa/patología , Piodermia Gangrenosa/terapia , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/secundario , Neoplasias Cutáneas/terapia , Vasculitis/complicaciones , Vasculitis/diagnóstico , Vasculitis/patología , Vasculitis/terapia , Heridas y Lesiones/diagnóstico
11.
Int Wound J ; 14(6): 955-959, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28326673

RESUMEN

Calciphylaxis (CPX) is a rare calcifying thrombotic vasculopathy responsible for painful necrotic ulcers, with a high mortality rate, and its management is often difficult. Recently, intravenous infusions of sodium thiosulfate (STS) have shown efficacy. The aim of this study was to assess the efficacy of intralesional STS (IL STS) in four patients. Our aim was to assess the efficacy of IL STS in a prospective mono-centric open study that included four patients with a biopsy-proven cutaneous CPX. Four women (55-84 years old, mean age: 71·2 years) with a uremic (n = 1) or non-uremic CPX (n = 3) and primary hyperparathyroidism induced by teriparatide or after the initiation of oral anti-vitamin K were treated by IL STS (250 mg/ml). The injections were performed around the ulcers, on the active borders, once or twice a week and then at 1-2 weeks intervals. The injected quantity varied from 1·5 to 15 ml. Pain usually improved after two series of injections. Clinical response was visible after 2 weeks. Three patients (75%) healed completely or almost completely. A failure was observed in the last patient who also had lower limb arteriopathy. The main side effect was the pain during injections. IL STS is an interesting alternative therapeutic option in the management of CPX necrotic ulcers with limited side effects. Larger studies are warranted to precisely define its place, its administration procedure and the patients who could benefit from it.


Asunto(s)
Antídotos/uso terapéutico , Calcifilaxia/tratamiento farmacológico , Úlcera de la Pierna/tratamiento farmacológico , Tiosulfatos/uso terapéutico , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Inyecciones Intralesiones , Persona de Mediana Edad , Estudios Prospectivos
12.
Duodecim ; 131(9): 863-70, 2015.
Artículo en Finés | MEDLINE | ID: mdl-26237885

RESUMEN

Actinic keratoses are premalignant skin lesions with the risk of converting into squamous cell carcinoma, and therefore they should be treated. Treatment modalities include cryotherapy, photodynamic therapy, carbon dioxide laser and also topical treatments such as imiquimode, ingenol mebutate, 5-fluorouracil and diclophenac. In the future, the treatment of actinic keratosis can be more often done in primary health care. The most favorable treatment modality depends on patient age, general health, and the thickness, size and localization of the lesion.


Asunto(s)
Queratosis Actínica/patología , Queratosis Actínica/terapia , Lesiones Precancerosas/patología , Lesiones Precancerosas/terapia , Administración Tópica , Aminoquinolinas/administración & dosificación , Antiinflamatorios no Esteroideos/administración & dosificación , Antineoplásicos/administración & dosificación , Crioterapia , Diclofenaco/administración & dosificación , Diterpenos/administración & dosificación , Fluorouracilo/administración & dosificación , Humanos , Imiquimod , Terapia por Láser , Fotoquimioterapia , Atención Primaria de Salud
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA